These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 28648578)

  • 1. Application of aptamers in treatment and diagnosis of leukemia.
    Yazdian-Robati R; Arab A; Ramezani M; Abnous K; Taghdisi SM
    Int J Pharm; 2017 Aug; 529(1-2):44-54. PubMed ID: 28648578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aptamer application in targeted delivery systems for diagnosis and treatment of breast cancer.
    Shahdordizadeh M; Yazdian-Robati R; Ramezani M; Abnous K; Taghdisi SM
    J Mater Chem B; 2016 Dec; 4(48):7766-7778. PubMed ID: 32263769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aptamer-drug conjugation for targeted tumor cell therapy.
    Donovan MJ; Meng L; Chen T; Zhang Y; Sefah K; Tan W
    Methods Mol Biol; 2011; 764():141-52. PubMed ID: 21748638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent Advances in SELEX Technology and Aptamer Applications in Biomedicine.
    Zhuo Z; Yu Y; Wang M; Li J; Zhang Z; Liu J; Wu X; Lu A; Zhang G; Zhang B
    Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29036890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances of aptamers screened by Cell-SELEX in selection procedure, cancer diagnostics and therapeutics.
    Zhong Y; Zhao J; Li J; Liao X; Chen F
    Anal Biochem; 2020 Jun; 598():113620. PubMed ID: 32087127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SELEX methods on the road to protein targeting with nucleic acid aptamers.
    Bayat P; Nosrati R; Alibolandi M; Rafatpanah H; Abnous K; Khedri M; Ramezani M
    Biochimie; 2018 Nov; 154():132-155. PubMed ID: 30193856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Voltammetric aptasensors for protein disease biomarkers detection: A review.
    Meirinho SG; Dias LG; Peres AM; Rodrigues LR
    Biotechnol Adv; 2016; 34(5):941-953. PubMed ID: 27235188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oligonucleotide aptamers: Recent advances in their screening, molecular conformation and therapeutic applications.
    Xiao X; Li H; Zhao L; Zhang Y; Liu Z
    Biomed Pharmacother; 2021 Nov; 143():112232. PubMed ID: 34649356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aptamers targeting cell surface proteins.
    Takahashi M
    Biochimie; 2018 Feb; 145():63-72. PubMed ID: 29198584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Highlight of Recent Advances in Aptamer Technology and Its Application.
    Sun H; Zu Y
    Molecules; 2015 Jun; 20(7):11959-80. PubMed ID: 26133761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SELEX--a (r)evolutionary method to generate high-affinity nucleic acid ligands.
    Stoltenburg R; Reinemann C; Strehlitz B
    Biomol Eng; 2007 Oct; 24(4):381-403. PubMed ID: 17627883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progress and Challenges in Developing Aptamer-Functionalized Targeted Drug Delivery Systems.
    Jiang F; Liu B; Lu J; Li F; Li D; Liang C; Dang L; Liu J; He B; Badshah SA; Lu C; He X; Guo B; Zhang XB; Tan W; Lu A; Zhang G
    Int J Mol Sci; 2015 Oct; 16(10):23784-822. PubMed ID: 26473828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aptamers evolved from cultured cancer cells reveal molecular differences of cancer cells in patient samples.
    Shangguan D; Cao ZC; Li Y; Tan W
    Clin Chem; 2007 Jun; 53(6):1153-5. PubMed ID: 17463173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FFF-based high-throughput sequence shortlisting to support the development of aptamer-based analytical strategies.
    Marassi V; Mattarozzi M; Toma L; Giordani S; Ronda L; Roda B; Zattoni A; Reschiglian P; Careri M
    Anal Bioanal Chem; 2022 Jul; 414(18):5519-5527. PubMed ID: 35182166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress in selection and biomedical applications of aptamers.
    Xi Z; Huang R; Deng Y; He N
    J Biomed Nanotechnol; 2014 Oct; 10(10):3043-62. PubMed ID: 25992428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted delivery of daunorubicin to T-cell acute lymphoblastic leukemia by aptamer.
    Taghdisi SM; Abnous K; Mosaffa F; Behravan J
    J Drug Target; 2010 May; 18(4):277-81. PubMed ID: 19943768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aptamers Targeting Membrane Proteins for Sensor and Diagnostic Applications.
    Kara N; Ayoub N; Ilgu H; Fotiadis D; Ilgu M
    Molecules; 2023 Apr; 28(9):. PubMed ID: 37175137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-SELEX optimization of aptamers.
    Gao S; Zheng X; Jiao B; Wang L
    Anal Bioanal Chem; 2016 Jul; 408(17):4567-73. PubMed ID: 27173394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in aptamer selection methods and applications.
    Yüce M; Ullah N; Budak H
    Analyst; 2015 Aug; 140(16):5379-99. PubMed ID: 26114391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of food matrices on aptamer selection by SELEX (systematic evolution of ligands by exponential enrichment) targeting the norovirus P-Domain.
    Schilling KB; DeGrasse J; Woods JW
    Food Chem; 2018 Aug; 258():129-136. PubMed ID: 29655714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.